compounded glp 1 vs tirzepatide semaglutide Compound: Clinical Differences – PlexusDx Fridays | GLP-1 Telehealth Brand-Name vs. Compounded GLP-1 |

10.1176/appi.ajp.2015.14101358 23 BolzS

As the battle over who gets what share of the multi-billion dollar obesity drug market continues, some patients are left wondering how they're going to get their next injections and from whom

In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)

doi: 10.1016/s0140-6736(75)90156-7 72 SchwartzRMBoyesSAynsley-GreenA

Retatrutide is not yet FDA-approved for obesity treatment as of publication date

Remedy Meds operates similarlyboth offer convenient GLP-1 access without in-person visits